Recorded fact · drug.label_indication

drug.label_indication for evolocumab|hypercholesterolemia

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 28de7298 resolves to.

The record

Fact id	`28de7298ef0a87546361f2d7`
Entity	drug: evolocumab\|hypercholesterolemia
Field	drug.label_indication
Source	api.fda.gov
Read on	2026-11-10T19:02:47.536Z
Source version	openfda-label-20241120
Method	extract
Verification	verified
Licence	CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels
Edition	2026-11, Merkle root `006ab9a329709cbe...`

The verifying quote

cholesterol (LDL-C)-lowering therapies, in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce LDL-C As an adjunct to diet and other LDL-C-lowering therapies in pediatric patients aged 10 years and

Shown with dashes as hyphens. SHA-256 of the exact stored quote: e88fb4e4921c29adb8e24066bd6a95cdd6f887975281c91586ab2fbefb024c9c.

The value

{
 "ingredient": "Evolocumab",
 "conditionId": "hypercholesterolemia",
 "conditionName": "Hypercholesterolemia",
 "matchedAlias": "hypercholesterolemia",
 "context": "indication",
 "brand": "REPATHA",
 "identifiedVia": "product_elements",
 "extractor": 5,
 "labelSetId": "709338ae-ab8f-44a9-b7d5-abaabec3493a",
 "labelEffectiveTime": "20241120",
 "labelsRead": 2,
 "labelsNaming": 2,
 "registryEditionRoot": "1b44e76f5da1a417",
 "meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}

SHA-256 of the exact stored value: 74630ae19d0ec7d22c208ceb43793d6428590ea35d266306bb33e2bfd74ce04d.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.